Correlation Between Neovacs SA and Novacyt
Can any of the company-specific risk be diversified away by investing in both Neovacs SA and Novacyt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and Novacyt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neovacs SA and Novacyt, you can compare the effects of market volatilities on Neovacs SA and Novacyt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of Novacyt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and Novacyt.
Diversification Opportunities for Neovacs SA and Novacyt
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Neovacs and Novacyt is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and Novacyt in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with Novacyt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt has no effect on the direction of Neovacs SA i.e., Neovacs SA and Novacyt go up and down completely randomly.
Pair Corralation between Neovacs SA and Novacyt
Assuming the 90 days trading horizon Neovacs SA is expected to generate 5.15 times more return on investment than Novacyt. However, Neovacs SA is 5.15 times more volatile than Novacyt. It trades about 0.03 of its potential returns per unit of risk. Novacyt is currently generating about -0.15 per unit of risk. If you would invest 0.03 in Neovacs SA on August 24, 2024 and sell it today you would lose (0.01) from holding Neovacs SA or give up 33.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 95.65% |
Values | Daily Returns |
Neovacs SA vs. Novacyt
Performance |
Timeline |
Neovacs SA |
Novacyt |
Neovacs SA and Novacyt Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neovacs SA and Novacyt
The main advantage of trading using opposite Neovacs SA and Novacyt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, Novacyt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt will offset losses from the drop in Novacyt's long position.Neovacs SA vs. Europlasma SA | Neovacs SA vs. Biophytis SA | Neovacs SA vs. Cellectis | Neovacs SA vs. Innate Pharma |
Novacyt vs. Biomerieux SA | Novacyt vs. Eurofins Scientific SE | Novacyt vs. Sartorius Stedim Biotech | Novacyt vs. SEB SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |